Wednesday, 14 October 2026 12:02 PM
Class Action
NEW YORK CITY, NY / ACCESS Newswire / October 14, 2026 / Levi & Korsinsky notifies investors that it has commenced an investigation into Johnson & Johnson ("Johnson & Johnson") (NYSE:JNJ) concerning potential violations of the federal securities laws.
Johnson & Johnson shareholders lost money when the stock fell sharply after the Company reported MedTech segment sales that missed Wall Street consensus expectations, despite beating overall adjusted EPS estimates and raising its full-year guidance. MedTech sales growth reached approximately 2.5% to roughly $8.6 billion, impacted by flat international sales, declining Surgery revenue, European budget cuts, China pricing pressures, and geopolitical factors affecting procedure volumes. The slowdown coincided with continuing investor concern over the orthopedic hips-and-knees business that the Company is considering spinning off. On a July 16, 2025 earnings call, Executive Vice President John Reed stated, "As already highlighted, we delivered a very strong second quarter, exceeding expectations on both the top and bottom line." However, Chief Financial Officer Joe Wolk disclosed that "In MedTech, results were not to our standards in cardiovascular, primarily heart recovery," having noted on an earlier call that "Our MedTech business delivered growth that fell below our expectations." Although filed SEC figures for the second quarter of 2026 recorded $8.926 billion in MedTech sales with 3.6% operational growth, international headwinds and market pricing pressures continued to weigh on overall market expectations. The investigation concerns whether Johnson & Johnson adequately disclosed the specific operational pressures, budget cuts, and pricing impacts in its MedTech segment ahead of its quarterly earnings release.
If you suffered a loss on your Johnson & Johnson securities and would like to explore a potential recovery under the federal securities laws, Learn More About the Investigation or contact Joseph E. Levi, Esq. via email at [email protected] or call (212)363-7500 to speak to our team of experienced shareholder advocates.
WHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
[email protected]
Tel: (212)363-7500
Fax: (212)363-7171
SOURCE: Levi & Korsinsky, LLP